**This Event has Past, Official Elsevier Webcast Coming Soon**
Overview
This live symposium will focus on the most current clinical trial data for achieving LDL-C goal for all patients in the era of PCSK9 inhibitors. The expert faculty will utilize an interactive panel format to translate evidence-based medicine to optimal clinical decision-making. The educational material of this symposium will provide information that every cardiologists needs to know to improve healthcare outcomes in their patients with cardiovascular disease.
This event is not part of the Official Scientific Sessions 2016 as planned by the AHA committee on Scientific Sessions Program.
Target Audience
Cardiologists, and other healthcare professionals responsible for the diagnosis, treatment or management of patients with dyslipidemia.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Review the science of PCSK9 inhibitors for patients with dyslipidemia.
- Analyze extended clinical trial data for PCSK9 inhibitors.
- Formulate personalized treatment plans to incorporate PCSK9 inhibitors to reduce risk and improve outcomes for patients with dyslipidemia.
Registration Fees
This is a complementary CME symposium
Agenda
6:30 – 7:00 PM – Registration and Dinner
7:00 – 7:10 PM – Introduction
7:10 – 7:25 PM – LDL-C Goals and Thresholds: Update 2016
7:25 – 7:35 PM – Interactive Expert Panel Discussion
7:35 – 7:55 PM – Recent Clinical Trial Data on PCSK9 Inhibitors
7:55 – 8:10 PM – Interactive Expert Panel Discussion
8:10 – 8:25 PM – Safety of PCSK9
8:25 – 8:35 PM – Interactive Expert Panel Discussion
8:35 – 8:50 PM – Practical Clinical Implications of PCSK9 Inhibition
8:50 – 9:00 PM – Case Presentation Series: Expert Faculty Panel
Accreditation Statement
AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
AcademicCME designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME INQUIRIES/SPECIAL NEEDS
For all CME inquiries or special needs, please contact
[email protected]
Financial Support
This activity has been supported by an independent educational grant from Amgen, Inc.
Provided By
Chair
Christopher P. Cannon, MD
Professor of Medicine
Harvard Medical School
Executive Director, Cardiometabolic Trials
Harvard Clinical Research Institute
Senior Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, MA
Faculty
Christie Ballantyne, MD
Professor of Medicine
Director, The Maria and Alando J. Ballantyne, M.D. Atherosclerosis Clinical Research Laboratory
Baylor College of Medicine
Co-director, Lipid Metabolism and Atherosclerosis Clinic
The Methodist Hospital
Director, Center for Cardiovascular Disease Prevention
Methodist DeBakery Heart Center
Houston, TX
Robert P. Giugliano, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Senior Physician, Division of Cardiovascular Medicine
Brigham and Women’s Hospital
Boston, MA
Steven E. Nissen, MD
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Chairman, Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH
James Underberg, MD
Clinical Assistant Professor of Medicine
New York University School of Medicine
New York Center for Prevention of Cardiovascular Disease
Director, Bellevue Hospital Lipid Clinic
New York, NY
